Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech equities.
Please send feedback and tips to christine.idzelis@marketwatch.com or isabel.wang@marketwatch.com. You can also follow me on X at @cidzelis and find me on LinkedIn. Isabel Wang is at @Isabelxwang.
Sign up here for our weekly ETF Wrap.
Some exchange-traded funds that buy biotech stocks are rallying in 2024.
The SPDR S&P Biotech ETF
,
with $8 billion of assets under management, as well as two much smaller ETFs in the biotech category, Virtus LifeSci Biotech Clinical Trials ETF
and the ALPS Medical Breakthroughs ETF
,
have all seen big gains both in February and this year to date, said Aniket Ullal, head of ETF data and analytics at CFRA Research, in a phone interview on…
